SI-BONE Inc
For the period ended Mar 31, 2024. Filed May 7, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 7, 2024
SIBN$25.10-2.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
(In thousands)
| Three Months EndedMarch 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Cash flows from operating activities | ||
| Net loss | $(10,904) | $(11,125) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Stock-based compensation | 7,030 | 6,194 |
| Depreciation and amortization | 1,089 | 1,086 |
| Accounts receivable credit losses | 82 | 50 |
| Amortization of discount and premium on marketable securities | (1,561) | (615) |
| Amortization of debt issuance costs | 42 | 81 |
| Loss on disposal of property and equipment | 388 | 190 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | (196) | (2,019) |
| Inventory | (772) | (536) |
| Prepaid expenses and other assets | 524 | 311 |
| Accounts payable | 2,371 | (745) |
| Accrued liabilities and other | (5,664) | (3,625) |
| Net cash used in operating activities | (7,571) | (10,753) |
| Cash flows from investing activities | ||
| Maturities of marketable securities | 67,000 | 30,000 |
| Purchases of marketable securities | (58,571) | (15,718) |
| Purchases of property and equipment | (2,082) | (2,579) |
| Net cash provided by investing activities | 6,347 | 11,703 |
| Cash flows from financing activities | ||
| Proceeds from debt financing | — | 36,000 |
| Repayments of debt financing | — | (35,275) |
| Payments of debt issuance costs | — | (40) |
| Proceeds from the exercise of stock options | 105 | 520 |
| Net cash provided by financing activities | 105 | 1,205 |
| Effect of exchange rate changes on cash and cash equivalents | (112) | 97 |
| Net increase (decrease) in cash and cash equivalents | (1,231) | 2,252 |
| Cash and cash equivalents at | ||
| Beginning of period | 33,271 | 20,717 |
| End of period | $32,040 | $22,969 |
| Supplemental disclosure of non-cash information | ||
| Unpaid purchases of property and equipment | 1,228 | 887 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.